Fentanyl (FEN) antibody and antigen (hapten, BSA/OVA conjugated)

 Download 

Product information

Catalog No.	Description	US $ Price (per mg)
GMP-SMT-232-Ag01	BSA-Fentanyl (FEN)	756
GMP-SMT-232-Ag02	OVA-Fentanyl (FEN)	756
GMP-SMT-232-Ab01	Anti-human Fentanyl (FEN) mouse monoclonal antibody (mAb)	1953
GMP-SMT-232-Ab02	Anti-human Fentanyl (FEN) human monoclonal antibody (mAb)	1953

Size： 1mg | 10mg | 100mg

Product Description

Cat No. of Products	GMP-SMT-232-Ag01
Product Name	BSA-Fentanyl (FEN)
Target/Biomarker	Fentanyl (FEN)
Expression platform	Synthetic
Isotypes	NA
Bioactivity validation	Fentanyl (FEN) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in FEN level test of Pain () and related syndrome evaluation.
Tag	NA
Products description	Competitive immunoassay-validated hapten-carrier conjugates BSA-Fentanyl (FEN) / OVA-Fentanyl (FEN) is Synthetic.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products	GMP-SMT-232-Ag02
Product Name	OVA-Fentanyl (FEN)
Target/Biomarker	Fentanyl (FEN)
Expression platform	Synthetic
Isotypes	NA
Bioactivity validation	Fentanyl (FEN) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in FEN level test of Pain () and related syndrome evaluation.
Tag	NA
Products description	Competitive immunoassay-validated hapten-carrier conjugates BSA-Fentanyl (FEN) / OVA-Fentanyl (FEN) is Synthetic.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products	GMP-SMT-232-Ab01
Product Name	Anti-human Fentanyl (FEN) mouse monoclonal antibody (mAb)
Target/Biomarker	Fentanyl (FEN)
Expression platform	Hybridoma
Isotypes	Mouse IgG
Bioactivity validation	Fentanyl (FEN) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in FEN level test of Pain () and related syndrome evaluation.
Tag	mFc
Products description	Competitive immunoassay-validated hapten-carrier conjugates BSA-Fentanyl (FEN) / OVA-Fentanyl (FEN) is Synthetic.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Competitive immunoassay validation (Competitive ELISA),Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products	GMP-SMT-232-Ab02
Product Name	Anti-human Fentanyl (FEN) human monoclonal antibody (mAb)
Target/Biomarker	Fentanyl (FEN)
Expression platform	Hybridoma
Isotypes	Mouse IgG
Bioactivity validation	Fentanyl (FEN) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in FEN level test of Pain () and related syndrome evaluation.
Tag	mFc
Products description	Competitive immunoassay-validated hapten-carrier conjugates BSA-Fentanyl (FEN) / OVA-Fentanyl (FEN) is Synthetic.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Competitive immunoassay validation (Competitive ELISA),Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference

Validation Data

Click to get more Data / Case study about the product.

Target/Biomarker information

Serial Number 1: Fentanyl and Its Role in In Vitro Diagnosis (IVD) Fentanyl, a synthetic opioid of immense potency, assumes a pivotal role in the realm of in vitro diagnosis (IVD). Our biopharmaceutical company, Genemedi, stands at the forefront of offering specialized tools to enable precise and sensitive detection of Fentanyl across diverse sample matrices. These encompass anti-Fentanyl antibodies and an extensive repertoire of small molecule competitive antigens, including Carrier-coupled antigens, immunogens, hapten-carrier conjugates, Bovine Serum Albumin (BSA)-conjugated, and Ovalbumin (OVA)-conjugated variants. These meticulously engineered reagents serve as indispensable assets for professionals in the fields of clinical diagnostics, forensic investigations, pharmacokinetic research, workplace safety, and public health surveillance. Serial Number 2: The Significance of Measuring Fentanyl a. Clinical Management: Fentanyl's role in clinical settings predominantly revolves around pain management. It is widely used for alleviating moderate to severe pain, often administered in various forms such as transdermal patches, lozenges, and injections. Measuring Fentanyl levels in patients undergoing pain management regimens is of paramount importance. It allows healthcare providers to ascertain the therapeutic efficacy of Fentanyl, ensuring that the patient's pain is adequately controlled while minimizing the risk of overdose. The precise quantification of Fentanyl in biological samples empowers clinicians to fine-tune dosage adjustments, tailor treatment plans, and optimize pain control strategies for individual patients. b. Forensic Investigations: Fentanyl, known for its remarkable potency, has gained notoriety in cases of drug abuse and overdose. In forensic investigations, the accurate measurement of Fentanyl assumes a critical role. It aids forensic experts and law enforcement agencies in determining the presence of Fentanyl in biological specimens, facilitating the elucidation of drug-related incidents and contributing to the gathering of crucial evidence. Whether it involves post-mortem examinations or the analysis of bodily fluids in criminal cases, Fentanyl testing is indispensable in unveiling the truth behind drug-related fatalities and criminal activities. c. Drug Compliance and Occupational Safety: The significance of measuring Fentanyl extends beyond clinical and forensic domains. In occupational settings where safety is paramount, particularly in industries such as transportation, heavy machinery operation, and law enforcement, ensuring sobriety and adherence to drug-free policies is critical. Workplace drug testing programs often include Fentanyl testing to confirm that employees are complying with safety regulations. It is a vital component of maintaining high safety standards, protecting both employees and the public from potential hazards associated with impaired individuals operating heavy machinery or performing safety-sensitive tasks. d. Pharmacokinetic Research: Researchers engaged in pharmacokinetic studies find Fentanyl measurement to be an indispensable tool. These studies delve into the absorption, distribution, metabolism, and excretion (ADME) dynamics of Fentanyl within the human body. The meticulous measurement of Fentanyl levels provides valuable insights into its pharmacokinetic profile. Researchers can track how Fentanyl is absorbed after administration, how it is distributed in various tissues, how it undergoes metabolism, and how it is eventually eliminated from the body. This information is vital for drug development and optimization, allowing pharmaceutical companies to formulate safe and effective Fentanyl-based medications and understand their behavior within the human body. e. Public Health Surveillance: The opioid epidemic has placed a spotlight on the need for comprehensive public health surveillance of opioid use, including Fentanyl. Monitoring Fentanyl levels within communities is instrumental in tracking and responding to opioid abuse trends. Public health organizations and authorities rely on data regarding Fentanyl presence to craft targeted interventions, formulate evidence-based policies, and allocate resources effectively to combat the opioid crisis. By monitoring Fentanyl, healthcare professionals and policymakers can gain valuable insights into the prevalence of Fentanyl use, the emergence of new analogs, and the geographical distribution of Fentanyl-related incidents. This data-driven approach aids in preventing overdose deaths, addressing addiction, and reducing the societal impact of opioid abuse. In conclusion, the precise quantification of Fentanyl holds multifaceted significance across various domains, encompassing clinical management, forensic science, workplace safety, pharmacokinetic research, and public health surveillance. Genemedi's specialized anti-Fentanyl antibodies and competitive antigens play a pivotal role in facilitating accurate Fentanyl detection, ultimately contributing to improved patient care, safety, scientific research, and public health initiatives.

About GDU